Kura Oncology, Inc. (KURA)
10.27
-0.29
(-2.75%)
USD |
NASDAQ |
Oct 30, 16:00
10.27
0.00 (0.00%)
After-Hours: 17:36
Kura Oncology Cash and Short Term Investments (Annual) : 667.24M for Dec. 31, 2025
Cash and Short Term Investments (Annual) Chart
Historical Cash and Short Term Investments (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 667.24M |
| December 31, 2024 | 727.40M |
| December 31, 2023 | 423.96M |
| December 31, 2022 | 437.98M |
| December 31, 2021 | 517.96M |
| December 31, 2020 | 633.32M |
| Date | Value |
|---|---|
| December 31, 2019 | 236.89M |
| December 31, 2018 | 178.98M |
| December 31, 2017 | 93.14M |
| December 31, 2016 | 67.79M |
| December 31, 2015 | 85.75M |
| December 31, 2014 | 1.124M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Annual) Benchmarks
| Inovio Pharmaceuticals, Inc. | 58.51M |
| Fortress Biotech, Inc. | 79.38M |
| Spero Therapeutics, Inc. | 40.26M |
| Gossamer Bio, Inc. | 136.93M |
| ACADIA Pharmaceuticals, Inc. | 819.69M |